Studies Open to Enrollment 2017-08-09T11:15:32+00:00

Studies Open to Enrollment

HPTN083

The main purpose of this clinical research trial is to see if cabotegravir, an antiretroviral medication can prevent infection with HIV in persons at high risk for HIV infection. 

The study will last 1.5 – 3 years and you may be eligible if you are:

  • 18 years of age or older
  • HIV negative
  • Sex assigned at birth was male
  • Gender – male or trans female
  • Have sex with men

 

This study is a double-blind study – all participants receive active medication but neither they nor the study staff will be aware of which medication they are getting.  All participants will receive an injection every 2 months and oral tablets that are taken once daily. 

Participants will be compensated for their time and will receive regular HIV testing and counseling, condoms and lubricant. 

A full description of the study is available at Clinical Trials Website.

If you are interested in this study – please contact Project WISH to arrange for a phone screen at 312-413-5897

The Principal Investigator is Richard M. Novak MD, Chief of Infectious Diseases, Department of Medicine, University of Illinois at Chicago. 

Prep

REPRIEVE

REPRIEVE Randomized Trial to Prevent Vascular Events in HIV

This clinical trial is testing to see if pitavastatin can prevent heart disease in people with HIV infection who are taking HIV medications. The study is a prospective, double-blind, randomized, placebo-controlled, multicenter phase IV efficacy study.  Participants are randomly assigned to either pitavastatin or placebo.  Pitavastatin has been approved by the FDA for a different use, to decrease cholesterol.

You may be eligible for REPRIEVE if you:

  • Have HIV and are between the ages of 40 and 75
  • Have been on antiretroviral therapy (ART) for at least 6 months
  • Have no history of cardiovascular disease
  • Are not currently taking a statin drug.

UIC  Principal Investigator: Richard M. Novak MD

For more information:

www.reprievetrial.org

www.clinicaltrials.gov

Project WISH 312-413-5897 Ariel Zuckerman, Research Nurse

 

DRIVE SHIFT STUDY: Investigational HIV drug

This study is evaluating the safety and effectiveness of an investigational medication for HIV-1 among participants who switch from one of several antiretroviral therapies. 


You may be eligible if you:

  • Have HIV and are at least 18 years of age.
  • Have been on a regimen of a Protease inhibitor (PI) and 2 NRTIs.
  • Are interested in switching medication.

 UIC Principal Investigator: Richard M. Novak MD

For more information:

Project WISH 312-413-9794 Regina Harden Study Coordinator

 

DRIVE BEYOND STUDY: Investigational HIV drug

This study is evaluating the safety and efficacy of an investigational medication among participants who have HIV-1 and have not previously taken a treatment medication for HIV.

¨

You may be eligible for this study if you:

  • Have HIV and are at least 18 years of age.
  • Have lab results that show one of 3 specific HIV genotypes.
  • Are willing to take an investigational medication.

 UIC Principal Investigator: Stockton Mayer D.O.

For more information:

Call Project WISH 312-413-5897 Regina Harden

 HPTN 083: Investigational HIV drug

HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent for pre-exposure prophylaxis (PrEP) in HIV-uninfected men and transgender women who have sex with men (MSM and TGW).

 

UIC  Principal Investigator: Richard M. Novak M.D

Study coordinator: John Stryker NP

Project WISH 312-413-5897

 

InFLUenza STUDIES

We offer three flu season studies, including a clinical trial of a treatment drug, and observational studies of influenza. If you are a UIH provider and have a patient who currently has flu-like symptoms or confirmed influenza, please call Project WISH at 312-413-5897.

UIC  Principal Investigator: Richard M. Novak M.D

Study coordinator: John Stryker NP

INSTRUCTIONS: In order to add a sidebar anchor:

  1. Duplicate the existing item, listed as a 1/6 text field. (Or create a 1/6 column and add a text field, modify the class so it’s exactly “additionalAnchor”).
  2. Modify the text field inside the 1/6 column. Inside there, modify the HYPERLINK so that it would go to a corresponding section with a “#” in front of it. (Example, we have a “chief” section on the page, then it would make sense to have the hyperlink go to “#chief”)
  3. Then change the hyperlink TEXT to a appropriate label.
  4. IMPORTANT: If not done already, go into that CONTAINER that corresponds to your anchor (i.e. Meet The Chiefs), and add an ID matching the anchor’s HYPERLINK WITHOUT the “#”, i.e. “chief”.
  5. (If using side bar widget box, then there’s a saved copy of a widget box COLUMN, grab it in the column library, it should 1/6 of a length of a column.)

NOTE: Order added to the sidebar is from last to first.